What is Straumann SLActive?
SLActive® is Straumann’s high performance surface for high predictability and accelerated osseointegration. Recent studies show an outstanding clinical performance of SLActive® implants even in very challenging treatment protocols.
What is Straumann implant made of?
Straumann® Roxolid® Roxolid® is a metal alloy composed of ~15 % zirconium and ~85 % titanium and has been specifically designed for use in dental implantology.
What is SLA implant?
Sandblasted, large grit, acid-etched implant surface, (SLA) is a type of surface treatment that creates surface roughness with the goal of enhancing osseointegration through greater bone-to-implant contact (BIC).
Where is Straumann implants made?
All major components of the Straumann Dental Implant System are currently manufactured at Straumann’s factory in Villeret, Switzerland.
What is RBM surface?
RBM (Resorbable Blast Media) surface treatment is designed to roughen the implant surface without leaving the residual embedded blast particles or debris in the treated substrate. It resolves completely the issues which can occur with SLA, or other surface treatment and deliver impeccable results.
What does SLA mean in dentistry?
Is Straumann German company?
Headquartered in Basel, Switzerland, the Straumann Group researches and develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry.
What is the difference between slactive® and Straumann SLA®?
In a recent preclinical study22, SLActive® showed significantly higher formation of new bone aggregate within eight weeks compared to the standard Straumann® SLA® hydrophobic surface. Buccal bone to implant contact was significantly higher in SLActive® groups as compared
Why choose Straumann slactive® implants?
Together with leading cli- nicians worldwide, Straumann has studied the clinical performance of SLActive® implants under the most challenging medical conditions and treat – ment protocols to demonstrate the outstanding healing capacity of the SLActive® surface.
What is slactive’s clinical development strategy?
the SLActive® clinical development strategy. Together with leading cli- nicians worldwide, Straumann has studied the clinical performance of SLActive® implants under the most challenging medical conditions and treat – ment protocols to demonstrate the outstanding healing capacity of the SLActive® surface.